| Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy L Hofmann, A Forschner, C Loquai, SM Goldinger, L Zimmer, S Ugurel, ... European journal of cancer 60, 190-209, 2016 | 672 | 2016 |
| Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy L Zimmer, SM Goldinger, L Hofmann, C Loquai, S Ugurel, I Thomas, ... European journal of cancer 60, 210-225, 2016 | 576 | 2016 |
| Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): evaluation and management of adverse drug reactions JC Hassel, L Heinzerling, J Aberle, O Bähr, TK Eigentler, MO Grimm, ... Cancer treatment reviews 57, 36-49, 2017 | 310 | 2017 |
| Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition MV Heppt, L Heinzerling, KC Kähler, A Forschner, MC Kirchberger, ... European Journal of Cancer 82, 56-65, 2017 | 190 | 2017 |
| CTLA4 as immunological checkpoint in the development of multiple sclerosis LA Gerdes, K Held, E Beltrán, C Berking, JC Prinz, A Junker, JK Tietze, ... Annals of neurology 80 (2), 294-300, 2016 | 105 | 2016 |
| Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma MV Heppt, A Roesch, B Weide, R Gutzmer, F Meier, C Loquai, KC Kähler, ... European Journal of Cancer 81, 36-44, 2017 | 103 | 2017 |
| Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy JK Tietze, DEC Wilkins, GD Sckisel, MN Bouchlaka, KL Alderson, ... Blood, The Journal of the American Society of Hematology 119 (13), 3073-3083, 2012 | 99 | 2012 |
| Characterization of mouse CD4 T cell subsets defined by expression of KLRG1 N Beyersdorf, X Ding, JK Tietze, T Hanke European journal of immunology 37 (12), 3445-3454, 2007 | 99 | 2007 |
| The proportion of circulating CD45RO+ CD8+ memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab JK Tietze, D Angelova, MV Heppt, M Reinholz, WJ Murphy, M Spannagl, ... European Journal of Cancer 75, 268-279, 2017 | 81 | 2017 |
| Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis MV Heppt, TK Eigentler, KC Kähler, RA Herbst, D Göppner, T Gambichler, ... Cancer Immunology, Immunotherapy 65, 951-959, 2016 | 80 | 2016 |
| Influenza infection results in local expansion of memory CD8+ T cells with antigen non-specific phenotype and function GD Sckisel, JK Tietze, AE Zamora, HH Hsiao, SO Priest, DEC Wilkins, ... Clinical & Experimental Immunology 175 (1), 79-91, 2014 | 61 | 2014 |
| Linear and volumetric evaluation of the adrenal gland—MDCT-based measurements of the adrenals J Schneller, M Reiser, F Beuschlein, A Osswald, A Pallauf, A Riester, ... Academic radiology 21 (11), 1465-1474, 2014 | 55 | 2014 |
| Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients JK Tietze, MV Heppt, A Von Preußen, U Wolf, T Ruzicka, H Wolff, ... Journal of the European Academy of Dermatology and Venereology 29 (9), 1816-1821, 2015 | 45 | 2015 |
| The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study JK Tietze, A Forschner, C Loquai, H Mitzel-Rink, L Zimmer, F Meiss, ... Oncotarget 9 (76), 34336, 2018 | 39 | 2018 |
| Frontal fibrosing alopecia: a retrospective analysis of 72 patients from a German academic center MV Heppt, V Letulé, I Laniauskaite, M Reinholz, JK Tietze, H Wolff, ... Facial Plastic Surgery 34 (01), 088-094, 2018 | 36 | 2018 |
| Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab–A report of 29 patients K Katzer, J Tietze, E Klein, V Heinemann, T Ruzicka, A Wollenberg European Journal of Dermatology 20 (1), 82-84, 2010 | 36 | 2010 |
| Rosazea K Gauwerky, W Klövekorn, HC Korting, P Lehmann, EM Meigel, D Reinel, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 7 (11), 996-1003, 2009 | 29 | 2009 |
| Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help AM Monjazeb, JK Tietze, SK Grossenbacher, HH Hsiao, AE Zamora, ... PloS one 9 (8), e102709, 2014 | 28 | 2014 |
| Low baseline levels of NK cells may predict a positive response to ipilimumab in melanoma therapy JK Tietze, D Angelova, MV Heppt, T Ruzicka, C Berking Experimental Dermatology 26 (7), 622-629, 2017 | 27 | 2017 |
| Combination therapy of melanoma using kinase inhibitors MV Heppt, JK Tietze, SA Graf, C Berking Current opinion in oncology 27 (2), 134-140, 2015 | 27 | 2015 |
